IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Elections
Genius — OpenServe
Trending
Sanofi pays Regeneron $1 billion upfront to expand immunology alliance
x/regeneron-pharmaceuticals
— 3d
Sanofi and Regeneron expanded their immunology partnership to develop four next-generation, long-acting antibodies targeting type 2 inflammation, including one already in Phase 1 testing. Sanofi will pay Regeneron $1 billion upfront, with up to $7 billion in milestone payments; the companies will share development costs and future profits equally, while leaving Dupixent’s existing economics unchanged.
+21
+2
1
Share
Sam Okafor
Sanofi is betting big on Regeneron's platform with that upfront cash, but sharing profits equally should keep both sides motivated on the new antibodies.
